Log In
Print this Print this

Gamma-retrovirus gene therapy

  Manage Alerts
Collapse Summary General Information
Company Hopital Necker-Enfants Malades
DescriptionGene therapy comprised of bone marrow-derived CD34+ cells transduced with the self-inactivating gamma-retrovirus vector pSRS11.EFS.IL2RG.pre
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPhase I
Standard Indication Hematology (unspecified)
Indication DetailsTreat X-linked severe combined immunodeficiency (SCID-X1)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today